Gilles Truan
Centre national de la recherche scientifique
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gilles Truan.
Gene | 1993
Gilles Truan; Christophe Cullin; Philippe Reisdorf; Philippe Urban; Denis Pompon
We have engineered yeast genomic DNA to construct a set of strains producing various relative amounts of yeast NADPH-P450 reductase (Yred) and human cytochrome b5 (Hb5). Expression of cDNAs encoding human P450 1A1, 1A2, 3A4, 19A and mouse P450 1A1 in the different oxido-reduction backgrounds thus constituted were achieved after strain transformation by plasmid-based P450-encoding expression cassettes. The results indicate that the level of Yred strongly affects all activities tested. In contrast, the amount of Hb5 affects activities in a manner that is dependent both on the P450 isoform considered and the Yred level. In a strain containing optimized amounts of Hb5 and Yred, human P450 3A4-specific testosterone-6 beta-hydroxylase activity can be enhanced as much as 73-fold in comparison with the activity observed in a wild-type strain. Bioconversion of sterols or xenobiotics was easily achieved in vivo using this new co-expression system.
Nucleic Acids Research | 2004
Jean Marie Rouillard; Woonghee Lee; Gilles Truan; Xiaolian Gao; Xiaochuan Zhou; Erdogan Gulari
There is substantial interest in implementing a bioinformatics tool that allows the design of oligonucleotides to support the development of in vitro gene synthesis. Current protocols to make long synthetic DNA molecules rely on the in vitro assembly of a set of short oligonucleotides, either by ligase chain reaction (LCR) or by assembly PCR. Ideally, such oligonucleotides should represent both strands of the final DNA molecule. They should be adjacent on the same strand and overlap the complementary oligonucleotides from the second strand to ensure good hybridization during assembly. This implies that the thermodynamic properties of each oligonucleotide have to be consistent across the set. Furthermore, any given oligonucleotide has to be totally specific to its target to avoid the creation of incorrectly assembled sequences. We have developed Gene2Oligo (http://berry.engin.umich.edu/gene2oligo/), a web-based tool that divides a long input DNA sequence into a set of adjacent oligonucleotides representing both DNA strands. The length of the oligonucleotides is dynamically optimized to ensure both the specificity and the uniform melting temperatures necessary for in vitro gene synthesis. We have successfully designed and used a set of oligonucleotides to synthesize the Saccharomyces cerevisiae cytochrome b5 by using both LCR and assembly PCR.
Gene | 1994
Gilles Truan; Jean-Charles Epinat; Claire Rougeulle; Christophe Cullin; Denis Pompon
Cytochrome P-450 (Cyp) 51 or lanosterol-C14-demethylase is the main target for antifungal compounds of the triazole family like ketoconazole (Kz). Disruption of the associated NADPH-P-450 reductase-encoding gene (YRED) is not lethal, but decreases by about 20-fold the Kz resistance (KzR) of wild-type (wt) Saccharomyces cerevisiae. Transformation of a YRED-disrupted strain by a yeast genomic library based on a multicopy vector allowed us to identify a suppressor of Kz hypersensitivity. Deletion analysis of the 5-kb cloned fragment indicated that yeast cytochrome b5-encoding gene (CYB5), which encodes a 120-amino-acid (aa) protein, is required and sufficient for the suppressor effect. The encoded polypeptide shares about 30% aa identity with mammalian cytochromes b5 (Cyb5). CYB5 disruption and tetrad analysis demonstrate that yeast Cyb5 is not required for growth in a Yred+ strain. Determination of the microsomal content of b-type cytochromes by differential spectra indicated the presence of a strongly decreased or null Cyb5 level in the disrupted strain. This confirms that we have cloned the gene encoding the major microsomal form of Cyb5 which appears not to be essential. Minor Cyb5 isoforms could also be present in yeast or other redox proteins could substitute for the pleiotropic roles of Cyb5 in the sterol and lipid biosynthesis pathways.
EMBO Reports | 2009
Louise Aigrain; Denis Pompon; Solange Moréra; Gilles Truan
Two catalytic domains, bearing FMN and FAD cofactors, joined by a connecting domain, compose the core of the NADPH cytochrome P450 reductase (CPR). The FMN domain of CPR mediates electron shuttling from the FAD domain to cytochromes P450. Together, both enzymes form the main mixed‐function oxidase system that participates in the metabolism of endo‐ and xenobiotic compounds in mammals. Available CPR structures show a closed conformation, with the two cofactors in tight proximity, which is consistent with FAD‐to‐FMN, but not FMN‐to‐P450, electron transfer. Here, we report the 2.5 Å resolution crystal structure of a functionally competent yeast–human chimeric CPR in an open conformation, compatible with FMN‐to‐P450 electron transfer. Comparison with closed structures shows a major conformational change separating the FMN and FAD cofactors from 86 Å.
FEBS Letters | 2010
Sylvie Cortial; Philippe Chaignon; Bogdan I. Iorga; Stéphane Aymerich; Gilles Truan; Virginie Gueguen-Chaignon; Philippe Meyer; Solange Moréra; Jamal Ouazzani
MINT‐7990140: nfrA1 (uniprotkb:P39605) and nfrA1 (uniprotkb:P39605) bind (MI:0407) by X‐ray crystallography (MI:0114)
Journal of Molecular Biology | 2009
Cécile Nouet; Gilles Truan; Lise Mathieu; Geneviève Dujardin
The mitochondrial protein Bcs1p is conserved from Saccharomyces cerevisiae to humans and its C-terminal region exhibits an AAA (ATPases associated with diverse cellular activities) domain. The absence of the yeast Bcs1p leads to an assembly defect of the iron-sulfur protein (ISP) subunit within the mitochondrial respiratory complex III, whereas human point mutations located all along the protein cause various pathologies. We have performed a structure-function analysis of the yeast Bcs1p by randomly generating a collection of respiratory-deficient point mutants. We showed that most mutations are in the C-terminal region of Bcs1p and have localized them on a theoretical three-dimensional model based on the structure of several AAA proteins. The mutations can be grouped into classes according to their respiratory competence and their location on the three-dimensional model. We have further characterized five mutants, each substituting an amino acid conserved in yeast and mammalian Bcs1 proteins but not in other AAA proteins. The effects on respiratory complex assembly and Bcs1p accumulation were analyzed. Intragenic and extragenic compensatory mutations able to restore complex III assembly to the mutants affecting the AAA domain were isolated. Our results bring new insights into the role of specific residues in critical regions that are also conserved in the human Bcs1p. We show that (1) residues located at the junction between the Bcs1p-specific and the AAA domains are important for the activity and stability of the protein and (2) the residue F342 is important for interactions with other partners or substrate proteins.
Biochemical Journal | 2011
Louise Aigrain; Denis Pompon; Gilles Truan
CPR (NADPH-cytochrome P450 reductase) is a multidomain protein containing two flavin-containing domains joined by a connecting domain thought to control the necessary movements of the catalytic domains during electronic cycles. We present a detailed biochemical analysis of two chimaeric CPRs composed of the association of human or yeast FMN with the alternative connecting/FAD domains. Despite the assembly of domains having a relatively large evolutionary distance between them, our data support the idea that the integrity of the catalytic cycle is conserved in our chimaeric enzymes, whereas the recognition, interactions and positioning of both catalytic domains are probably modified. The main consequences of the chimaerogenesis are a decrease in the internal electron-transfer rate between both flavins correlated with changes in the geometry of chimaeric CPRs in solution. Results of the present study highlight the role of the linker and connecting domain in the recognition at the interfaces between the catalytic domains and the impact of interdomain interactions on the redox potentials of the flavins, the internal electron-transfer efficiency and the global conformation and dynamic equilibrium of the CPRs.
International Journal of Molecular Sciences | 2012
Louise Aigrain; Fataneh Fatemi; Oriane Frances; Ewen Lescop; Gilles Truan
Diflavin reductases are essential proteins capable of splitting the two-electron flux from reduced pyridine nucleotides to a variety of one electron acceptors. The primary sequence of diflavin reductases shows a conserved domain organization harboring two catalytic domains bound to the FAD and FMN flavins sandwiched by one or several non-catalytic domains. The catalytic domains are analogous to existing globular proteins: the FMN domain is analogous to flavodoxins while the FAD domain resembles ferredoxin reductases. The first structural determination of one member of the diflavin reductases family raised some questions about the architecture of the enzyme during catalysis: both FMN and FAD were in perfect position for interflavin transfers but the steric hindrance of the FAD domain rapidly prompted more complex hypotheses on the possible mechanisms for the electron transfer from FMN to external acceptors. Hypotheses of domain reorganization during catalysis in the context of the different members of this family were given by many groups during the past twenty years. This review will address the recent advances in various structural approaches that have highlighted specific dynamic features of diflavin reductases.
Biocatalysis and Biotransformation | 2003
Valérie Abécassis; Philippe Urban; Lawrence P. Aggerbeck; Gilles Truan; Denis Pompon
Abstract Two complementary methods are described that associate in vitro and in vivo steps to generate sequence diversity by segment directed saturated mutagenesis and family shuffling. A high-throughput DNA chip-based procedure for the characterization and potentially the equalization of combinatorial libraries is also presented. Using these approaches, two combinatorial libraries of cytochrome P450 variants derived from the CYP1A subfamily were constructed and their sequence diversity characterized. The results of functional screening using high-throughput tools for the characterization of membrane P450-catalyzed activities, suggest that the 204–214 sequence segment of human CYP1A1 is not critical for polycyclic aromatic hydrocarbon recognition, as was hypothesized from previous data. Moreover, mutations in this segment do not alter the discrimination between alkoxyresorufins, which, for all tested mutants, remained similar to that of wild-type CYP1A1. In contrast, the constructed CYP1A1–CYP1A2 mosaic structures, containing multiple crossovers, exhibit a wide range of substrate preference and regioselectivity. These mosaic structures also discriminate between closely related alkoxyresorufin substrates. These results open the way to global high-throughput analysis of structure–function relationships using combinatorial libraries of enzymes together with libraries of structurally related substrates.
Journal of Biomolecular NMR | 2010
Marcela Nunez; Eric Guittet; Denis Pompon; Carine van Heijenoort; Gilles Truan
Cytochrome b5 (cytb5) is a small membrane-bound hemoprotein present in all eukaryotic organisms. In most eukaryotic cells, cytb5 is attached to the cytosolic face of the endoplasmic reticulum and is described as the microsomal form (Mc). In vertebrates, two supplementary cytb5 can be found: soluble in the erythrocytes and membrane-bound attached to the internal face of the outer membrane in the mitochondria (OM) (Wang et al. 2007). Cytb5 can be divided into three domains: an N-terminal hydrosoluble globular domain that contains approximately 90 residues, a C-terminal hydrophobic domain about 25 residues long and a linker between the two above-mentioned domains. The hydrophilic domain contains the redox center, an iron protoporphyrin IX, ligated to the apoprotein by two histidyl residues. Mc cytb5 transfers electrons to various acceptors and is consequently involved in many different metabolic pathways. In the mixed function oxidase system, Mc cytb5 is a facultative electron donor to cytochromes P450 (Vergeres and Waskell 1995). Several mechanisms for the recognition between cytb5 and its physiological or artificial acceptors have been hypothesized. The implication of electrostatic interactions has been mostly studied with the cytochromes P450 as acceptors and is now widely accepted as a dominant factor (Schenkman et al. 1994). Nonetheless, several other factors may contribute positively to the recognition mechanism. First, the soluble domain of cytb5 lacking its C-terminal membrane domain cannot transfer electrons to membrane electron acceptors like cytochrome P450 (Dailey and Strittmatter 1978) while the full-length cytb5 can transfer electrons to both soluble and membranebound electron acceptor proteins (Vergeres and Waskell 1995). The linker is also recognized as an important factor controlling cytb5 to P450 interactions (Clarke et al. 2004). The three dimensional structures of the oxidized or reduced soluble domain of wild-type and mutant cytb5 from different species have been determined, either by X-ray or NMR. So far, no three dimensional structure of the full length protein has been reported, although some solid-state NMR data of the full-length rabbit cytb5 inserted in bicelles was Electronic supplementary material The online version of this article (doi:10.1007/s10858-010-9428-6) contains supplementary material, which is available to authorized users.
Collaboration
Dive into the Gilles Truan's collaboration.
Piotr Résidence du Cnrs Bât. Abc Slonimski
Centre national de la recherche scientifique
View shared research outputs